Newly identified T cell subsets in mechanistic studies of food immunotherapy
نویسندگان
چکیده
منابع مشابه
T cell adoptive immunotherapy of newly diagnosed gliomas.
Patients with newly diagnosed gliomas were treated with adoptive transfer of ex vivo activated T lymphocytes, derived from lymph nodes (LNs) draining autologous tumor vaccines, to determine the long-term toxicity of this treatment. Twelve consecutive patients were enrolled: 2 with grade II astrocytoma, 4 with anaplastic gliomas, and 6 with glioblastoma multiforme. Patients were injected intrade...
متن کاملChanges Among T-Cell Subsets Identified by V, Epitope Expression
Background Cellular rejection of an allograft is mediated in part by peripheral blood T cells. We tested the hypothesis that quantitative changes in T-cell subsets can be detected in the peripheral blood and that these changes correlate with rejection. Methods and Results T-cell subset analysis was performed by flow cytometry using monoclonal antibodies recognizing six isotypic epitopes of the ...
متن کاملthe newly identified t helper 22 cells lodge in leukemia.
leukemia is a hematological tumor in which the malignant myeloid or lymphoid subsets play a pivotal role. newly identified t helper cell 22 (th22) is a subset of cd4(+) t cells with distinguished gene expression, function and specific properties apart from other known cd4(+) t cell subsets.th22 cells are characterized by production of a distinct profile of effector cytokines, including interleu...
متن کاملimbalance of t-cell subsets in iranian allergic rhinitis patients
r'iwenty-nine patients were studied to determine the number of cj).j+ tscell subsets in iranian allergic rhinitis patients. the result was compared with that a/twenty-four nonatopic controls. the number of11 and cds+t cell')and levels ofspeafic ige and /g(;4 against weed pollens were also studied the number of lymphocyte subset, tltat is, cd-/+ c/)29+and c1jf cj)451t cells were determined hy do...
متن کاملDynamics of cytotoxic T cell subsets during immunotherapy predicts outcome in acute myeloid leukemia
Preventing relapse after chemotherapy remains a challenge in acute myeloid leukemia (AML). Eighty-four non-transplanted AML patients in first complete remission received relapse-preventive immunotherapy with histamine dihydrochloride and low-dose interleukin-2 in an international phase IV trial (ClinicalTrials.gov; NCT01347996). Blood samples were drawn during cycles of immunotherapy and analyz...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Clinical Investigation
سال: 2019
ISSN: 0021-9738,1558-8238
DOI: 10.1172/jci124605